This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oo, C.
Right arrow Articles by Ward, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oo, C.
Right arrow Articles by Ward, P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2002, p. 1993-1995, Vol. 46, No. 6
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.6.1993-1995.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Lack of Pharmacokinetic Interaction between the Oral Anti-Influenza Prodrug Oseltamivir and Aspirin

Charles Oo,1* Joanne Barrett,2 Albert Dorr,1 Baolian Liu,1 and Penelope Ward3

F. Hoffman-La Roche, Nutley, New Jersey,1 Roche Global Development, Welwyn,,2 GlaxoSmithKline, Brentford, Middlesex, United Kingdom3

Received 15 October 2001/ Returned for modification 4 January 2002/ Accepted 11 March 2002

Twelve volunteers completed a two-sequence, three-way crossover study of a single 900-mg aspirin dose and multiple doses of 75 mg of oseltamivir in the absence and presence of 900 mg of aspirin. The plasma and urine results demonstrated no pharmacokinetic interaction between oseltamivir and aspirin.


* Corresponding author. Mailing address: Hoffmann-La Roche, Inc., Dept. of Clinical Pharmacology, 340 Kingsland St., Nutley, NJ 07110. Phone: (973) 562-2575. Fax: (973) 235-5635. E-mail: charles.oo{at}roche.com.


Antimicrobial Agents and Chemotherapy, June 2002, p. 1993-1995, Vol. 46, No. 6
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.6.1993-1995.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Shi, D., Yang, J., Yang, D., LeCluyse, E. L., Black, C., You, L., Akhlaghi, F., Yan, B. (2007). Response to Comments on "Anti-Influenza Prodrug Oseltamivir Is Activated by Carboxylesterase Human Carboxylesterase 1, and the Activation Is Inhibited by Antiplatelet Agent Clopidogrel". J. Pharmacol. Exp. Ther. 322: 424-425 [Full Text]